Aditya Humad grew up in India and the Middle East. He graduated from the University of Pennsylvania at the Wharton School of Business and the School of Engineering.
Aditya Humad met Dr. Kingsley R. Chin in 2003. His business experience started with J.P.Morgan on Wall Street in New York as a healthcare investment analyst.where he focused on healthcare M&A, capital raise and restructuring transactions
before joining KICVentures in 2009. Aditya Humad has closed multiple M&A deals for KICVentures, most recently AxioMed and NanoFUSE Biologics. He brought focused financial oversight in raising over $30M in equity and debt capital for KICVentures.
Aditya Humad has a Bachelor's in both Bioengineering and Finance from the University of Pennsylvania and Wharton School of Business as part of the prestigious Jerome Fisher Management & Technology Program.